Tela Bio Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Tela Bio Inc 's ROA in the second quarter of 2026?
Tela Bio Inc recorded a cumulative net loss of $-41 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -60.42%.

However, within the Healthcare sector 615 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3999, from total ROA ranking in the first quarter of 2026 at 4634.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-11.55 %	-9.53 %	-5.95 %	16.17 %	12.18 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-41	-40	-39	-39	-41
Return On Assets (TTM)	-60.42 %	-56.83 %	-53.97 %	-53.25 %	-57.34 %
TELA's Total Ranking	# 3999	# 4634	# 4051	# 4156	# 4293
Total Assets (TTM) in million	60	70	81	62	68
Seq. Total Assets Change	-14.53 %	-14.16 %	32.2 %	-8.81 %	-12.57 %
Seq. Net Income Change	-	-	-	-	-

TELA's 5 Years Annual ROA >> Back to TELA Management Effectiveness >> Compare TELA ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 151
Sector	# 616
Overall	# 3999

Return On Assets Statistics
High	Average	Low
-21.51 %	-53.06 %	-70.61 %
(Jun 30 2020)		(Mar 31 2023)

Financial Statements
Tela Bio Inc 's Assets	$ 60 million	TELA's Balance sheet
Tela Bio Inc 's Income	$ -11 million	Quarterly TELA's Income Statement
TELA's Income by Division		See TELA's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-5.95 %	10.92 %	15.02 %	8.49 %	-27.66 %
Total Assets in million	81	87	78	68	63
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-39	-38	-47	-44	-33
Annual Return On Assets	-47.69 %	-43.71 %	-59.79 %	-65.28 %	-53.2 %

TELA's 5 Years Annual ROA >> Back to TELA Management Effectiveness >> Compare TELA ROA to its Competitors

More Return On Assets Ratios
TELA's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TELA's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TELA's Competitors
Subscribers only: Roa for Tela Bio Inc 's Suppliers
Subscribers only: Return On Assets for TELA's Customers

You may also want to know
TELA's Roi	TELA's Inventory Turnover Ratio	TELA's Growth Rates	TELA's Dividend Comparisons
	TELA's Profitability Ratios	TELA's Asset Turnover Ratio	TELA's Dividend Growth
TELA's Roe	TELA's Valuation Ratios	TELA's Financial Strength Ratios	TELA's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:38:37+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.